- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.04. | iTonic Holdings (ITOC) Stock Surges Over 66% After Hours: Why Is It Moving? | 1 | Benzinga.com | ||
| 23.04. | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | 172 | GlobeNewswire (Europe) | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 23.04. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 24.03. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 26.01. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13.01. | Pheton Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.01. | Pheton Holdings to change name to iTonic, ticker to ITOC | 2 | Seeking Alpha | ||
| ITONIC Aktie jetzt für 0€ handeln | |||||
| 13.01. | Pheton Holdings Ltd. Announces Corporate Name Change and Stock Ticker Symbol Change | 1.328 | GlobeNewswire (Europe) | BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 16.12.25 | Pheton Holdings Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 05.12.25 | Pheton Holdings schließt Übernahme von 51 % an KI-Gesundheitsunternehmen iTonic ab | 5 | Investing.com Deutsch | ||
| 05.12.25 | Pheton Holdings completes acquisition of 51% stake in iTonic | 1 | Investing.com | ||
| 05.12.25 | Pheton Holdings Ltd. Announces Closing of Share Acquisition with iTonic | 447 | GlobeNewswire (Europe) | Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen | |
| 05.12.25 | Pheton Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.11.25 | Pheton Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.10.25 | Pheton Holdings Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 733 | GlobeNewswire (Europe) | Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and... ► Artikel lesen | |
| 01.08.25 | Pheton Holdings Ltd. Issues Statements Addressing Recent Market Activity and Misleading Rumors | 696 | GlobeNewswire (Europe) | BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company," "we," "our" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 5,190 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic | HOUSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ORGANON | 11,315 | 0,00 % | Organon & Co.: Europäische Kommission erteilt Marktzulassung für POHERDY (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,720 | -9,47 % | Co-Diagnostics JV secures KSA facility lease deal; CODX rallies 16% premarket | ||
| SENSEONICS | 4,680 | -4,49 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| VIRIDIAN THERAPEUTICS | 14,400 | -2,04 % | XFRA 1S1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILVIRIDIAN THERAPEUTICS... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,800 | +2,72 % | Inspire Medical Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| EMBECTA | 2,902 | +2,15 % | Embecta stock rating held at Neutral by BTIG after investor meetings | ||
| VYOME | 1,990 | +1,02 % | Vyome: Positive Phase-2-Daten für Wundbehandlung bei Krebspatienten | ||
| PROCEPT BIOROBOTICS | 28,730 | +8,62 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 35,760 | +3,26 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 22,800 | +12,43 % | TACTILE SYSTEMS TECHNOLOGY INC - 8-K, Current Report | ||
| APYX MEDICAL | 3,480 | +4,82 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| GLAUKOS | 116,00 | +1,75 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,597 | -1,29 % | Lexaria Bioscience Corp.: Lexaria Bioscience Releases Second Episode of Investor Video Series | CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities KELOWNA, BC / ACCESS Newswire / May 7, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,920 | -13,47 % | Incannex Healthcare Inc. - 8-K, Current Report |
ITONIC HOLDINGS LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -2,38 % bei einem Aktienkurs von 0,304 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ITONIC HOLDINGS LTD finden Sie auf Wallstreet Online.